MedPath

A randomised clinical trial of internet-based treatment for binge drinking and depression in young Australians

Not Applicable
Conditions
Depression
Alcohol Misuse
Mental Health - Depression
Mental Health - Addiction
Registration Number
ACTRN12614000310662
Lead Sponsor
niversity of New South Wales
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
369
Inclusion Criteria

Participants will be between the ages of 18-30 and living in Australia, with low mood (score at least 12 on the Depression Anxiety and Stress Scale - 21) and binge drinking (binge drinking at least 2 times in the previous month, where a binge is 5 or more standard drinks in one sitting, as measured by the Time Line Follow Back).

Exclusion Criteria

People who cannot understand English sufficiently to complete the various assessments and DEAL program. People who do not have access to the internet (either in their private residence, or do not have a willingness to use the public library/other suitable venues with internet access).

In NSW it is illegal to buy alcohol for or sell alcohol to people under 18 years of age, so they have been excluded from this research. This study does not include those aged over 30 as it is focusing on treatment of young people who are notoriously more difficult to engage and retain in traditional treatment services than are adults.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depressive symptoms (as measured by the Depression, Anxiety Stress Scale - 21 item; and the Structured Clinical Interview for DSM - Depression).[Baseline and 26, 39, 52 and 64-weeks post-baseline (DASS-21). Baseline, 26 and 52-weeks post-baseline for the SCID - Depression).];Alcohol use (as measured by the Alcohol Use Disorders Identification Test; the Alcohol Time Line Follow Back and the Structured Clinical Interview for DSM - Alcohol).[Baseline and 26, 39, 52 and 64-weeks post-baseline (AUDIT and TLFB). Baseline, 26 and 52-weeks post-baseline for the SCID - Alcohol).]
Secondary Outcome Measures
NameTimeMethod
Other drug use (tobacco, cannabis and caffeine) as measured by the Opiate Treatment Index and the Drug Use History.[At baseline and 26, 39, 52 and 64-weeks post-baseline.];Quality of Life as measured by the AQoL-6D[At baseline and 26, 39, 52 and 64-weeks post-baseline.]
© Copyright 2025. All Rights Reserved by MedPath